BIO-key International, Inc.
BKYI
$0.727
-$0.0261-3.47%
| Weiss Ratings | BKYI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | BKYI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BKYI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.38 | |||
| Price History | BKYI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.05% | |||
| 30-Day Total Return | -28.02% | |||
| 60-Day Total Return | -68.11% | |||
| 90-Day Total Return | -19.22% | |||
| Year to Date Total Return | -47.70% | |||
| 1-Year Total Return | -61.53% | |||
| 2-Year Total Return | -95.07% | |||
| 3-Year Total Return | -98.09% | |||
| 5-Year Total Return | -99.34% | |||
| 52-Week High % Change | -79.54% | |||
| 52-Week Low % Change | 45.19% | |||
| Price | BKYI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.68 | |||
| 52-Week Low Price | $0.52 | |||
| 52-Week Low Price (Date) | Oct 16, 2024 | |||
| 52-Week High Price (Date) | Jan 15, 2025 | |||
| Valuation | BKYI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.80M | |||
| Enterprise Value | 4.14M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -10.12 | |||
| Earnings Per Share Growth | -61.51% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.22 | |||
| Price/Book (Q) | 17.60 | |||
| Enterprise Value/Revenue (TTM) | 0.65 | |||
| Price | $0.73 | |||
| Enterprise Value/EBITDA (TTM) | -0.47 | |||
| Enterprise Value/EBIT | -0.45 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BKYI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.89M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BKYI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 732 359 1100 | |||
| Address | 101 Crawfords Corner Road Holmdel, NJ 07753 | |||
| Website | www.bio-key.com | |||
| Country | United States | |||
| Year Founded | 1993 | |||
| Profitability | BKYI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -144.97% | |||
| Profit Margin | -142.18% | |||
| Management Effectiveness | BKYI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -71.73% | |||
| Return on Equity | -- | |||
| Income Statement | BKYI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 6.39M | |||
| Total Revenue (TTM) | 6.39M | |||
| Revenue Per Share | $3.38 | |||
| Gross Profit (TTM) | 944.80K | |||
| EBITDA (TTM) | -8.79M | |||
| EBIT (TTM) | -9.27M | |||
| Net Income (TTM) | -9.09M | |||
| Net Income Avl. to Common (TTM) | -9.09M | |||
| Total Revenue Growth (Q YOY) | 18.03% | |||
| Earnings Growth (Q YOY) | 59.79% | |||
| EPS Diluted (TTM) | -10.12 | |||
| EPS Diluted Growth (Q YOY) | 87.86% | |||
| Balance Sheet | BKYI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.80M | |||
| Cash Per Share (Q) | $0.95 | |||
| Total Current Assets (Q) | 4.55M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 133.00K | |||
| Current Ratio (Q) | 0.775 | |||
| Book Value Per Share (Q) | $0.04 | |||
| Total Assets (Q) | 6.40M | |||
| Total Current Liabilities (Q) | 5.87M | |||
| Total Debt (Q) | 2.46M | |||
| Total Liabilities (Q) | 6.27M | |||
| Total Common Equity (Q) | 133.00K | |||
| Cash Flow | BKYI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -24.10K | |||
| Cash from Financing (TTM) | 5.22M | |||
| Net Change in Cash (TTM) | 1.49M | |||
| Levered Free Cash Flow (TTM) | -140.00K | |||
| Cash from Operations (TTM) | -3.93M | |||
